Cargando…
Interrelations between COVID-19 and other disorders
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/ https://www.ncbi.nlm.nih.gov/pubmed/33333255 http://dx.doi.org/10.1016/j.clim.2020.108651 |
_version_ | 1783642087700299776 |
---|---|
author | Gasmi, Amin Peana, Massimiliano Pivina, Lyudmila Srinath, Shvetha Gasmi Benahmed, Asma Semenova, Yuliya Menzel, Alain Dadar, Maryam Bjørklund, Geir |
author_facet | Gasmi, Amin Peana, Massimiliano Pivina, Lyudmila Srinath, Shvetha Gasmi Benahmed, Asma Semenova, Yuliya Menzel, Alain Dadar, Maryam Bjørklund, Geir |
author_sort | Gasmi, Amin |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease’s prognosis and how severe the outcome can be expected. |
format | Online Article Text |
id | pubmed-7833539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78335392021-01-26 Interrelations between COVID-19 and other disorders Gasmi, Amin Peana, Massimiliano Pivina, Lyudmila Srinath, Shvetha Gasmi Benahmed, Asma Semenova, Yuliya Menzel, Alain Dadar, Maryam Bjørklund, Geir Clin Immunol Review Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease’s prognosis and how severe the outcome can be expected. Elsevier Inc. 2021-03 2020-12-14 /pmc/articles/PMC7833539/ /pubmed/33333255 http://dx.doi.org/10.1016/j.clim.2020.108651 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Gasmi, Amin Peana, Massimiliano Pivina, Lyudmila Srinath, Shvetha Gasmi Benahmed, Asma Semenova, Yuliya Menzel, Alain Dadar, Maryam Bjørklund, Geir Interrelations between COVID-19 and other disorders |
title | Interrelations between COVID-19 and other disorders |
title_full | Interrelations between COVID-19 and other disorders |
title_fullStr | Interrelations between COVID-19 and other disorders |
title_full_unstemmed | Interrelations between COVID-19 and other disorders |
title_short | Interrelations between COVID-19 and other disorders |
title_sort | interrelations between covid-19 and other disorders |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/ https://www.ncbi.nlm.nih.gov/pubmed/33333255 http://dx.doi.org/10.1016/j.clim.2020.108651 |
work_keys_str_mv | AT gasmiamin interrelationsbetweencovid19andotherdisorders AT peanamassimiliano interrelationsbetweencovid19andotherdisorders AT pivinalyudmila interrelationsbetweencovid19andotherdisorders AT srinathshvetha interrelationsbetweencovid19andotherdisorders AT gasmibenahmedasma interrelationsbetweencovid19andotherdisorders AT semenovayuliya interrelationsbetweencovid19andotherdisorders AT menzelalain interrelationsbetweencovid19andotherdisorders AT dadarmaryam interrelationsbetweencovid19andotherdisorders AT bjørklundgeir interrelationsbetweencovid19andotherdisorders |